Cepheid’s Q2 revenue did not fall across the board as was originally reported; clinical product sales increased 135 percent during the period. Also, the company had around $80.5 million in marketable securities as of June 30.
 
NEW YORK (GenomeWeb News) – Cepheid yesterday reported a 7-percent drop in second-quarter revenues as products and services declined in most segments.
 
The news caused shares in the company to trade down 18.7 percent, or $1.62, to $7.05 mid-afternoon today.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.